This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish (read more).

Commercial Packaging

Speciality Dosage Forms

The true value in a global partner is the ability to successfully guide a product through the various phases of clinical development as well as successfully meet the divergent demands of ongoing commercial supply and speciality dosage forms

Our experience in commercial product launch is unparalleled. PCI affords its customers agility in a dynamic commercial market, with the flexibility to adapt quickly to changing market demands and capitalize on market opportunities.

We support the needs of a diverse portfolio of products and speciality delivery forms, incorporating both traditional and emerging technologies including:

  • Solid Oral Dose
  • Combination Therapies
  • Liquids
  • Gels
  • Powders
  • Parenterals Including Transdermal Patches, Autoinjectors, Pens and other Injectables, Eye Care Applications
  • Cold Chain Products
  • Controlled Substances
  • Specialized Products Including Biologics, Hormonal Products, Cytotoxins and Potent Products
  • Medical Devices and Combination Products

European Falsified Medicine Directive (FMD) (2011/62/EU)

WE CAN HELP YOU WITH YOUR COMPLIANCE

We are industry leaders in product security for global medicines with significant Serialization and Anticounterfeiting technologies. Find out how our experienced teams can work with you to understand your exact requirements to ensure your product’s integrity and protect patient safety.

Our experienced team will work with you to understand exact serialization requirements

Enquire Today - Our experienced team will work with you to understand exact serialization requirements


Our dedicated team of specialists will be happy to discuss our Commercial Packaging & speciality dosage forms. Contact us on +1 779-774-1428 (US) or +44 1495 711 222 (UK) or email sales@pciservices.com


Expansion of High Potent Tableting and Powder Modification Capacity

Investment in new technologies at PCI’s global manufacturing Center of Excellence in Tredegar, Wales, to double highly potent tableting capacity... View Article

PCI Welcomes New Chief Financial Officer and SVP, Serge Dupuis

PCI is pleased to welcome Serge Dupuis as Senior Vice President and Chief Financial Officer. Serge’s appointment supports PCI’s continued... View Article

x